Dr. Joel Zachry Stengel, MD

Dr. Stengel practices at South Broward Endoscopy in Cooper City, Florida.

Dr. Stengel's NPI, 1124040654, was assigned on July 24, 2006. Dr. Stengel graduated from University of Miami, Miller School of Medicine in 2002. Dr. Stengel holds Florida license ME89914.

Dr. Stengel's primary practice is South Broward Endoscopy, at 11011 Sheridan Street, Suite 106, Cooper City, FL 33026. The practice phone is (954) 435-0101.

Dr. Stengel's primary practice is South Broward Endoscopy in Cooper City, Florida. Dr. Stengel is also affiliated with Memorial Regional Hospital. The medical group on file is Gastro Health. Dmand AI also links Dr. Stengel to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stengel practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Stengel's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Stengel is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Stengel is licensed in Florida.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Stengel treats.

CMS data shows 448 Medicare services from Dr. Stengel across 9 procedure codes in 2024, for 285 Medicare patients. Medicare paid $41,141 for them.

CMS counts 285 Medicare patients who saw Dr. Stengel in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stengel's median patient age at 56, with 55% women.

In 2024, Dr. Stengel wrote 1,233 Medicare Part D claims for 434 patients. 78% of them were for generic drugs. CMS names the drug for 1,046 of them, across 25 drugs with 11 or more claims each, at $187,448 in total drug cost. In 2023, CMS named 968 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Stengel for performance year 2024, reported as part of a group. Dr. Stengel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 78 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Stengel, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Stengel, published from 2008 to 2010. 2010 was the busiest year, with 3. The most frequent topics are Colonoscopy and Polyethylene Glycols. Dr. Stengel's most frequent co-authors are Hays L. Arnold, MD, Michael Carl Hjelkrem, MD and Christopher Dirk Williams, MD.

CMS Open Payments shows 790 general payments to Dr. Stengel from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,534.

Dmand AI lists 1 award for Dr. Stengel, most recently CMS Stage 1 EHR in 2014.

Dr. Stengel graduated from University of Miami, Miller School of Medicine in 2002. Dr. Stengel is a member of ACG and ASGE.

Dr. Stengel is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.